Regulatory Challenges in Autologous Therapies Regulatory Strategy in 2023 – Playbook 11 Regulatory Challenges in Autologous Therapies Regulatory Strategy in 2023 – Playbook 11 The advancement of autologous therapies, particularly in the domain of cell therapy, presents unique regulatory challenges. As the landscape continues to evolve, regulatory professionals require a comprehensive understanding of the various stages involved in the regulatory pathway. This guide offers a step-by-step approach to navigate the complexities of regulatory strategy in the United States for autologous therapies in 2023. It emphasizes practical actions and required documentation, making it an essential resource for professionals engaged in cell…